Evaluation of a Clinical Decision Support System for Fungal Infections

Status Completed

Clinical Trial Summary

Invasive fungal infections are serious and frequent diseases in our hospitals, especially in intensive care units. In accordance with the institutional recommendations, it is necessary to have a clinical decision support system to support the clinicians in a rapid and optimal prescription of antifungals for invasive fungal diseases. This clinical decision support system will benefit patients but also clinicians who will gain in medical efficiency. It will also have an ethical dimension since it will guarantee optimal antifungal treatments for all patients. The purpose of the research is to define the percentage of concordance between the medical prescription and the recommendation of the clinical decision support system.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05656157
Study type	Observational
Source	Hospices Civils de Lyon
Contact
Status	Completed
Phase
Start date	December 1, 2022
Completion date	November 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05749380` - Pharmacokinetics and Safety of AmBisome and DKF-5122	Phase 1
Not yet recruiting	`NCT02527928` - Cost-Effectiveness of Amphotericin B	N/A
Completed	`NCT02851680` - Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia.	N/A
Completed	`NCT03572049` - Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole	Phase 2/Phase 3
Recruiting	`NCT05534529` - Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age	Phase 1
Completed	`NCT04024995` - Revision of Antifungal Strategies Definitions for Invasive Fungal Infections in Hematological Malignancies
Completed	`NCT00745992` - Voriconazole Blood Level and Liver Metabolizing Enzyme in Taiwanese Patients
Completed	`NCT06413056` - Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection	Phase 4
Recruiting	`NCT05130723` - Pharmacokinetics of Fluconazole in Children (2-18 Years)
Recruiting	`NCT04157465` - Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients	N/A
Completed	`NCT04122560` - Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration	Phase 4
Completed	`NCT03262584` - Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
Completed	`NCT02678598` - A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections	N/A
Completed	`NCT05491733` - A Bioequivalence Study of APX001 High-load and Low-load Tablets	Phase 1
Not yet recruiting	`NCT06220370` - PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.
Completed	`NCT04777058` - Pharmacokinetics of Isavuconazole in Patients in the Intensive Care Unit
Recruiting	`NCT03583164` - Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options	Phase 2
Completed	`NCT03174457` - Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study
Completed	`NCT00750737` - Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)	Phase 3
Not yet recruiting	`NCT06346951` - Survey on the Current Status of IFD Diagnosis and Treatment by Intensive Care Physicians in Sichuan Province (IFS)